NCHA submitted a comment letter to the Health Resources and Services Administration on the proposed rule that would make Jan. 1, 2019 the effective date for implementing the final regulations regarding the 340B Drug Pricing Program ceiling price and drug manufacturers’ civil monetary penalties for violations of the ceiling price. NCHA urges HRSA to publish the final rule in time to implement the Jan. 1, 2019 deadline and to publish the ceiling price website as soon as possible.